FDA.reportPublic FDA data

Ilevro 3 MG/ML Ophthalmic Suspension

RxCUI
1365866
RxNorm name
Ilevro 3 MG/ML Ophthalmic Suspension
Display name
Ilevro 3 MG/ML Ophthalmic Suspension
Full name
Ilevro 3 MG/ML Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ILEVRONEPAFENACNovartis Pharmaceuticals Corporationf089b583-0310-4ca8-8d41-52b06b08d1ed2026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1365866
ILEVRONEPAFENACHarrow Eye, LLC10f411d3-a81e-074a-e063-6294a90ab5472026-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1365866

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
10f411d3-a81e-074a-e063-6294a90ab547Ilevro 0.3 % Ophthalmic SuspensionSY5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
10f411d3-a81e-074a-e063-6294a90ab547ILEVRO 0.3 % Ophthalmic SuspensionPSN5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
10f411d3-a81e-074a-e063-6294a90ab547nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]SBD5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
10f411d3-a81e-074a-e063-6294a90ab547Ilevro 3 MG/ML Ophthalmic SuspensionSY5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
f089b583-0310-4ca8-8d41-52b06b08d1edIlevro 3 MG/ML Ophthalmic SuspensionSY5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
f089b583-0310-4ca8-8d41-52b06b08d1edIlevro 0.3 % Ophthalmic SuspensionSY5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
f089b583-0310-4ca8-8d41-52b06b08d1edILEVRO 0.3 % Ophthalmic SuspensionPSN5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401
f089b583-0310-4ca8-8d41-52b06b08d1ednepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]SBD5These highlights do not include all the information needed to use ILEVRO ® safely and effectively. See full prescribing information for ILEVRO. ILEVRO ® (nepafenac ophthalmic suspension), topical ophthalmic Initial U.S. Approval: 200520260401